N,N-Dimethylglycine in patients with progressive multiple sclerosis: result of a pilot double-blind, placebo, controlled randomized clinical trial

N,N-Dimethylglycine in patients with progressive multiple sclerosis: result of a pilot double-blind, placebo, controlled randomized clinical trial

Abstract Oral administration of N,N-Dimethylglycine (DMG), a tertiary amino acid, presumably enhances oxygen utilization by tissue and complex with free radicals. Beneficial effects are improved endurance performance and reduction fatigue in humans and animals. This pilot study reports the results o...

Full description

Bibliographic Details
Main Authors: Thomas Wolfsegger, Klaus Böck, Wolfgang Schimetta, Tim J. von Oertzen, Hamid Assar
Format: Article
Language:English
Published: BMC 2021-05-01
Series:Neurological Research and Practice
Subjects:
N,N-Dimethylglycine
Multiple sclerosis
Nutrition therapy
Dietary supplement
Mobility
Online Access:https://doi.org/10.1186/s42466-021-00126-z

Internet

https://doi.org/10.1186/s42466-021-00126-z

Similar Items